Clinical trials
Completed Dyslipidemias trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 3 |
| Novartis Pharmaceuticals | 2 |
| Shaoguan University | 2 |
| The George Institute for Global Health, China | 2 |
| Abbott | 1 |
| Amgen | 1 |
| Amway (China) R&D Center | 1 |
| AstraZeneca | 1 |
| Central South University | 1 |
| Eddingpharm (Zhuhai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 30 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Hypertension | 3 |
| Atherosclerosis | 2 |
| Hypercholesterolemia | 2 |
| Hyperlipidemias | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Hypertriglyceridemia | 2 |
| Inflammation | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.